Cyanotech Corp. (CYAN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.660.00 (0.00%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close3.66
Bid3.66 x 200
Ask3.90 x 500
Day's Range3.66 - 3.66
52wk Range3.32 - 6.14
1y Target EstN/A
Market Cap20.68M
P/E Ratio (ttm)-4.11
Avg Vol (3m)4,229
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire3 days ago

    Cyanotech® Corporation Earns Non-GMO Project Verification for BULK SCE BioAstin® Natural Astaxanthin Products

    Cyanotech® Corporation , is proud to announce that its bulk raw material BioAstin® SCE products have received Non-GMO Project Verification. BioAstin Natural Astaxanthin is a potent natural antioxidant that provides natural support for joint, skin, eye and brain health.* BioAstin is derived from natural microalgae, Haematococcus pluvialis, cultivated and grown on the Kona coast of the Big Island of ...

  • American City Business Journalslast month

    Cyanotech reports quarterly loss

    Cyanotech Corp. (Nasdaq Capital Market: CYAN), a Kailua-Kona-headquartered maker of microalgae-based nutrition and health products, announced Tuesday that it had a net loss of $691,000, or 12 cents per diluted share, during its first quarter of fiscal year 2017 compared with a net loss of $105,000, or 2 cents per diluted share, for the first quarter of FY 2016. Net sales were $7.32 million for the most-recent quarter compared with $7.59 million, a decrease of 3.6 percent.

  • Business Wirelast month

    Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017

    Cyanotech Corporation , a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2017, ended June 30, 2016.